Governor Deval Patrick spoke yesterday at the Cambridge Innovation Center–emphasizing the importance of entrepreneurs to the Commonwealth’s economy and crediting them with being instrumental in the advent of late-night MBTA service.  Patrick was introduced by Carlos Martinez-Velam Executive Director of the Venture Cafe Foundation. 

—Anita M. Harris

–New Cambridge Observer is a publication of the Harris Communications Group, an award-winning pr and marketing firm based at the Cambridge Innovation Center, in Cambridge, MA. 

        Later today, I hope to attend the Clean-Tech Meetup–an event which,  Gov. Deval Patrick, has said, “brings together innovative leaders from across the Commonwealth, the country and the globe to grow businesses, advance technologies and expand the adoption of clean energy sources.”

             As described on the Clean Tech Meetup Web site,  “through  Clean Energy Week and the Conference on Clean Energy in Boston,”  Massachusetts has been “steadily growing” a community of clean energy innovators and implementers.   “Now, we’re using what we’ve learned to bring you an event focusing on connecting people in intimate settings—instead of panels or keynotes.”

• Major Energy Consumers, Utilities, Leading Cleantech Companies, and other companies looking to form partnerships will meet providers of innovative clean energy services, products, and technologies.
• Investors will meet over 50 companies from more than 10 countries, hear from emerging clean energy companies, and talk with major energy users about their needs for clean energy technologies.
• Emerging Clean Energy Companies will talk with potential investors, strategic partners, and customers.

View the conference program.

Innovation Tour:  The conference also includes a tour of “cool companies and organizations” that will be holding open houses”from  Kendall Square to the Seaport Innovation District,” on Wednesday.  View the Tour participants.

I’m pleased that my friend and informal client, Christine Adamow, President and CEO of EuphorbUS,   announced today that her company, , a  “tree-based”  biofuel company that  has operated in East Africa since 2007,  will soon open its first operating site in North America in Hawaii.

The Meetup  is pricey, with registration $400+ for  participants and  $500-$1000 for presenters, who are selected by the conference organizations. (Might say I was surprised that the organizers called the event a meetup– because most “meetups” I’ve heard of are free or nearly so).   Held at the Boston Convention Center, it  runs through Wednesday.

—Anita M. Harris

Governor Deval Patrick and Medicon Valley Officials after signing collaboration agreement at 2012 Bio International Convention on 6/20/12. Photo by Anita Harris, Harris Communications Group.

“It’s not about what we can give you or take; it’s about how we can share.” So said Massachusetts Governor Deval Patrick before signing a collaboration agreement with officials from Medicon Valley MOU –located in the Capital Region of Denmark, Region Zealand in Denmark and Region Skåne in Sweden. The  agreement was one of two  partnerships signed today between Massachusetts and European regions. The second was with Catalonia, Spain.  Both  agreements were signed at the BIO International Convention.

“Our innovation economy is thriving here in Massachusetts and establishing and encouraging international partnerships is an important part of our future growth,” Governor Patrick said. “Catalonia and Medicon Valley are important regions in Europe’s innovation sector, and these partnerships will allow us to move forward on our mutual goals in this part of the global economy.”

The Medicon Valley memo of understanding (MOU) was signed by Governor Patrick and officials from the Capital Region of Denmark, Region Zealand in Denmark and Region Skåne in Sweden.

The agreement focuses on enhancing research partnerships in life sciences by an exchange of researchers and students; identifying special projects, partnerships or collaborations that can lead to new or enhanced research opportunities; and establishing a framework to be used in joint projects that could be financed by the European Union or National Institute of Health to develop new products and processes that can be used in the global market, according to a press release furnished by the governor’s office.

Medicon Valley is a bi-national region composed of the island of Zealand in eastern Denmark and the Skåne region of southern Sweden. It is home to over 200 companies in biotech, med-tech, and pharmaceuticals with over 350 additional companies in those fields having affiliate or branch offices in the region. These industries employ 40,000 people.

The MOU with Catalonia, Spain was signed by Governor Patrick and the President of Catalonia, Spain Artur Mas I Gavarro, with U.S. Ambassador to Spain Alan Solomont present for the signing. The Patrick-Murray Administration has partnered with the Catalan Government to put real collaboration into a renewed agreement on the 20^th anniversary of Lieutenant Governor Paul Cellucci signing a Declaration of Intent of Cooperation in 1992 between Massachusetts and Catalonia, according to the release.

The agreement facilitates collaboration in the following areas:

a)         Bilateral cooperation in research, and technological and industrial innovation;

b)         Business cooperation and economic development in key productive sectors, especially in life sciences, renewable energy, information technology, advanced manufacturing and infrastructure, and;

c)         Academic cooperation.

Catalonia has pursued a policy similar to Governor Patrick’s of investing in the innovation economy. Areas of convergence include the life sciences, mobile devices, clean energy technology, and advanced infrastructure. In 2011, Spain was Massachusetts’ 21st largest export partner, with Massachusetts exporting approximately $326.99 million worth of goods and services.

The BIO International Convention provides Governor Patrick, Lieutenant Governor Timothy Murray, state and industry leaders with an opportunity to showcase Massachusetts as a global leader in the life sciences industry, and the preeminent place for life sciences companies to invest in and expand. On Tuesday, Governor Patrick announced the first round of grants awarded under the Massachusetts-Israel Innovation Partnership (MIIP). MIIP is a formal collaboration between the State of Israel and the Commonwealth of Massachusetts to encourage and support innovation and entrepreneurship between Massachusetts’ and Israel’s life sciences, clean energy and technology sectors. A total of at least $1.3 million is being awarded to four research & development (R&D) collaborations between Massachusetts and Israeli companies that have been jointly approved by the funding agencies on both sides. The total budget of the awarded projects is estimated at approximately $3 million. The Massachusetts awardees are located in Natick, Needham, North Billerica and Wilbraham.

Earlier on Wednesday, the Governor joined seven global biopharmaceutical companies to announce the formation of the Massachusetts Neuroscience Consortium. Participating companies include Abbott, Biogen Idec, EMD Serono, Janssen Research & Development, LLC, Merck, Pfizer and Sunovion Pharmaceuticals Inc. The Consortium will fund pre-clinical neuroscience at Massachusetts academic and research institutions.

Governor Patrick’s ten-year, $1 billion life sciences investment package has strengthened the state’s global leadership in the life sciences. The initiative melds all of the state’s key resources in order to spur research, investment, innovation and commercialization. Now the life sciences industry in Massachusetts is thriving, with more than 52 percent job growth in the biopharma sector since 2001 and more than 80,000 employees working in the life sciences.

–Anita M. Harris
New Cambridge Observer is a publication of the Harris Communications Group, an award-winning  public relations and marketing communications agency located in Cambridge, MA.

###

The Wall Street Journal editorializes rabidly that the about-to-be adopted health reform will cost  multitrillions of dollars, that health insurers will become regulated public utilities, that Big Pharma, the American Medical Association, the American Hospital Association, the Federation of American Hospitals, the Business Roundtable  and even  Wal-Mart “have made themselves more vulnerable to the gilded clutches of the political class…all leading to higher taxes, slower economic growth and worse medical care.”

The New York Times calls the reform a triumph for countless Americans who have been victimized or neglected by their dysfunctional health care system…providing coverage to tens of millions of uninsured Americans, prevent the worst insurance company abuses, and begin to wrestle with relentlessly rising costs — while slightly reducing future deficits.

The Boston Globe says that the reform has split Massachusetts along party lines.

According to the Globe:

 Republican gubernatorial candidate  Charles D. Baker Jr., a former health insurance CEO, believes  the package will “increase the deficit and result in higher taxes or cuts in federal aid for teaching hospitals, medical device companies, and other health care firms that make up one-third of the Massachusetts economy.”

  Independent candidate  State Treasurer Tim Cahill  says the legislation will “wipe out the American economy within four years.’’

 I do believe that  taxes will go up;  that  government involvement will create confusion and extra layers of bungling bureaucracy; and that, because I’ll be on Medicare by the time it’s fully enacted, it won’t benefit me personally, at all.

But every developed nation but one believes its citizens deserve to stay alive and well. 

Healthier people are more energetic and productive;  nipping disease before it reaches costly later stages will save money in the long run; perhaps some oversight will focus more attention on streamlining hospital practices or unnecessary care.

While the legislation needs tweaking and will be subject to change, I firmly support it. It’s the right thing to do.